Attachment 3. Screener and Survey Invitation Email MIA Study Wave1

OMB No: [FILL NUMBER] Expiration Date: [FILL DATE]

Paperwork Reduction Act Statement: According to the Paperwork Reduction Act of 1995, an agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a valid OMB control number. The time required to complete this information collection is estimated to average 1 minute per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other aspects of this collection of information, including suggestions for reducing burden to [email protected]

Attachment 3. Screener Invitation Email

Screener Invitation Email to Parent

Email Subject: A New KnowledgePanel Survey for You! Survey on Media and Advertisements

Email Body:

Dear <<Name>>

Thanks for being an integral part of KnowledgePanel! We have a new survey for you. The study is sponsored by the United States Food and Drug Administration (FDA). Your participation in the study is voluntary.

Please click the link below to get started.

[link to screener and survey]

Our Panel Member Support Center is available if you have questions or comments. You can contact us toll free at 1-800-782-6899, or simply reply to this email invitation. To better serve you, please be sure to reference [PROJECT ASSIGNMENT NUMBER] in the subject of your message. We are always happy to hear from you! If you have any questions about your rights as a study participant, you can contact Advarra IRB by email at [email protected], or by phone at 1-877-992-4724 (a toll-free number). Please reference the following number when contacting the Study Subject Adviser: [insert protocol number].

Thanks,

The KnowledgePanel Team

Screener Invitation Email to Participant

Email Subject: A New KnowledgePanel Survey for You! Survey on Media and Advertisements

Email Body:

Thanks for being an integral part of KnowledgePanel! We have a new survey for you. The study is sponsored by the United States Food and Drug Administration (FDA). Your participation in the study is voluntary.

Please click the link below to get started.

[insert link to survey]

Our Panel Member Support Center is available if you have questions or comments. You can contact us toll free at 1-800-782-6899, or simply reply to this email invitation. To better serve you, please be sure to reference [PROJECT ASSIGNMENT NUMBER] in the subject of your message. We are always happy to hear from you! If you have any questions about your rights as a study participant, you can contact Advarra IRB by email at [email protected], or by phone at 1-877-992-4724 (a toll-free number). Please reference the following number when contacting the Study Subject Adviser: [insert protocol number].

Thanks,

The KnowledgePanel Team